Effect of Oral Magnesium Oxide Supplementation on Cisplatin-Induced Hypomagnesemia in Cancer Patients: A Randomized Controlled Trial
Background: Hypomagnesaemia is one of the main side effects of cisplatin-based chemotherapy regimens in cancer patients. The aim of the current investigation was to evaluate the effect of oral magnesium oxide (MgO) supplementation on cisplatin-induced hypomagnesemia. Methods: This parallel-randomi...
Main Authors: | Maryam ZARIF YEGANEH, Masoud VAKILI, Ali SHAHRIARI-AHMADI, Marzieh NOJOMI |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2016-02-01
|
Series: | Iranian Journal of Public Health |
Subjects: | |
Online Access: | https://ijph.tums.ac.ir/index.php/ijph/article/view/5845 |
Similar Items
-
Evaluation of Intravenous MagnesiumSupplementation as Prophylaxis forCisplatin-induced Hypomagnesemia
by: Marjaneh Mirsadraee, et al.
Published: (2010-07-01) -
FOCUS ON MAGNESIUM BASED DRUGS
by: I. I. Esenova
Published: (2016-01-01) -
Effect of Magnesium on Reducing Arrhythmias in Patients after CABG Surgery
by: Alireza Mohammadzadeh, et al.
Published: (2016-04-01) -
Helicobacter pylori infection and serum magnesium in kidney disease; current concepts
by: Banafsheh Yalameha, et al.
Published: (2020-01-01) -
The role of magnesium supplementation in cisplatin-induced nephrotoxicity in a rat model: No nephroprotectant effect
by: Farzaneh Ashrafi, et al.
Published: (2012-01-01)